Search Within

Lu Wang

Formats
  1. Meeting Abstract (75)
  2. Journal Article (71)
  3. Book Section (1)
Groups
  1. Department of Pathology and Laboratory Medicine (140)
  2. GSK Faculty (87)
  3. Human Oncology and Pathogenesis Program (83)
  4. Tow Center for Developmental Oncology (TCDO) (75)
  5. Department of Medicine (71)
  6. Solid Tumor Oncology Division (55)

More Groups

People
  1. Marc Ladanyi (68)
  2. Meera Hameed (41)
  3. Michael Berger (34)
  4. Maria Arcila (31)
  5. Mark Kris (25)
  6. Ahmet Zehir (16)

More People

Years
  1. 2020 (1)
  2. 2019 (3)
  3. 2018 (10)
  4. 2017 (23)
  5. 2016 (29)
  6. 2015 (33)

More Years

Publications
  1. Modern Pathology (28)
  2. Laboratory Investigation (18)
  3. Journal of Molecular Diagnostics (15)
  4. Journal of Clinical Oncology (8)
  5. Journal of Thoracic Oncology (8)
  6. Clinical Cancer Research (6)

More Publications

Publishers
  1. Nature Research (28)
  2. Nature Publishing Group (25)
  3. American Association for Cancer Research (17)
  4. Elsevier Science, Inc. (16)
  5. Elsevier Inc. (13)
  6. American Society of Clinical Oncology (8)

More Publishers

Results (147)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Small-cell lung cancers in patients who never smoked cigarettes
    Journal Article

    Varghese, A. M.; Zakowski, M. F.; Yu, H. A.; Won, H. H.; Riely, G. J.; Krug, L. M.; Kris, M. G.; Rekhtman, N.; Ladanyi, M.; Wang, L.; more...
    Journal of Thoracic Oncology (2014)

    Fulltext@MSK | Save
  • A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations
    Journal Article

    Kohsaka, S.; Shukla, N.; Ameur, N.; Ito, T.; Ng, C. K. Y.; Wang, L.; Lim, D. ; Marchetti, A.; Viale, A.; Pirun, M.; more...
    Nature Genetics (2014)

    Fulltext@MSK | Save
  • Genetics of melanotic schwannomas - A pilot study by SNP-array analysis
    Meeting Abstract

    Wang, L.; Zhou, J.; Agaram, N.; Patel, T.; Rosenblum, M.; Hameed, M.
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • Invasive status rather than nuclear features correlate with outcome in encapsulated follicular tumors: A comparative analysis of encapsulated papillary thyroid carcinoma follicular variant, encapsulated follicular carcinoma and follicular adenoma
    Meeting Abstract

    Ganly, I.; Wang, L.; Tuttle, R. M.; Cerioni, V.; Harach, R.; Ghossein, R.
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • Patterns of metastasis and survival in patients with PI3K pathway-driven stage IV squamous cell lung cancers (SQCLC)
    Meeting Abstract

    Paik, P. K.; Moreira, A. L.; Wang, L.; Won, H. H.; Hasanovic, A.; Rekhtman, N.; Sima, C. S.; Ladanyi, M.; Berger, M. F.; Kris, M. G.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Screening for RET and ROS1 fusions in an enriched cohort of pan-negative never-smokers with advanced lung adenocarcinomas to identify patients for treatment in targeted therapy trials
    Meeting Abstract

    Drilon, A. E. D.; Wang, L.; Hasanovic, A.; Joubert, P.; Kris, M. G.; Riely, G. J.; Ladanyi, M.; Rizvi, N. A.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Prospective molecular evaluation of small cell lung cancer (SCLC) utilizing the comprehensive mutation analysis Program at Memorial Sloan-Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Pietanza, M. C.; Varghese, A.; Won, H.; Rekhtman, N.; Wang, L.; Travis, W. D.; Paik, P. K.; Riely, G. J.; Zakowski, M. F.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Patterns of metastasis and survival in patients with PI3K-aberrant and FGFR1 amplified stage IV squamous cell lung cancers (SQCLCs)
    Meeting Abstract

    Paik, P. K.; Moreira, A. L.; Wang, L.; Rekhtman, N.; Sima, C. S.; Won, H.; Ladanyi, M.; Berger, M. F.; Kris, M. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Inhibition of the IGF-1R signaling pathway potentiates responses to ALK inhibitors in both ALK TKI naive and ALK TKI resistant lung cancer
    Meeting Abstract

    Lovly, C. M.; McDonald, N. T.; Chen, Y. L. H.; Jin, H. L.; Lim, D.; Suehara, Y.; Wang, L.; Johnson, D. H.; Horn, L.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • FGFR1 amplification is associated with improved survival in patients with early-stage squamous cell carcinomas of the lung (SQCLC)
    Meeting Abstract

    Hellmann, M. D.; Wynne, M.; Wang, L.; Kris, M. G.; Sima, C. S.; Moreira, A. L.; Rekhtman, N.; Paik, P. K.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save